Jennison Associates’s Damora Therapeutics DMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding DMRA
Jennison Associates's DMRA Position: Q3 2026 in Review
Jennison Associates opened a new position in Damora Therapeutics (DMRA) in Q3 2026: 212,425 shares worth $4.52M. The stake represents ﹤0.01% of the portfolio and ranks #427 among its holdings.
115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.
- Jennison Associates held 212,425 shares of Damora Therapeutics worth $4.52M as of Q3 2026.
- Damora Therapeutics was a new Jennison Associates position in Q3 2026.
- Damora Therapeutics made up ﹤0.01% of Jennison Associates's portfolio in Q3 2026, its #427 holding.
- 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.
Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.